Comparison of Heart Rate Variability Analysis Durations and Their Relationship With Blood Pressure
HRV-BP
1 other identifier
interventional
40
1 country
1
Brief Summary
This observational study aims to compare heart rate variability (HRV) parameters obtained from different analysis durations in healthy adults and to examine how these parameters relate to resting blood pressure values. HRV is a noninvasive measure commonly used to assess autonomic nervous system activity. Standard short-term HRV analysis is typically based on 5-minute recordings, but shorter and longer analysis durations are also used in research and practice. This study will evaluate whether HRV values derived from 1-minute, 5-minute, 10-minute, and 20-minute analysis windows differ from one another and whether their relationships with systolic blood pressure, diastolic blood pressure, and mean arterial pressure change according to analysis duration. Participants will attend a single study visit. After a rest period, resting blood pressure and pulse will be measured, and a continuous HRV recording will be obtained using a chest strap device. The study is designed to provide methodological information on the comparability of different HRV analysis durations under the same physiological conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
April 15, 2026
April 1, 2026
4 months
April 6, 2026
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
RMSSD Across Different Analysis Durations
Root mean square of successive differences (RMSSD), in milliseconds (ms), calculated from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same continuous resting RR interval recording obtained under standardized resting conditions.
Baseline, during a single study visit
SDNN Across Different Analysis Durations
Standard deviation of normal-to-normal intervals (SDNN), in milliseconds (ms), calculated from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same continuous resting RR interval recording obtained under standardized resting conditions.
Baseline, during a single study visit
Low-Frequency Power Across Different Analysis Durations
Low-frequency (LF) power, in ms\^2, calculated from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same continuous resting RR interval recording obtained under standardized resting conditions.
Baseline, during a single study visit
High-Frequency Power Across Different Analysis Durations
High-frequency (HF) power, in ms\^2, calculated from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same continuous resting RR interval recording obtained under standardized resting conditions.
Baseline, during a single study visit.
LF/HF Ratio Across Different Analysis Durations
Low-frequency/high-frequency (LF/HF) ratio calculated from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same continuous resting RR interval recording obtained under standardized resting conditions.
Baseline, during a single study visit.
Secondary Outcomes (12)
Agreement of RMSSD Across Different Analysis Durations
Baseline, during a single study visit
Agreement of SDNN Across Different Analysis Durations
Baseline, during a single study visit
Agreement of Low-Frequency Power Across Different Analysis Durations
Baseline, during a single study visit
Agreement of High-Frequency Power Across Different Analysis Durations
Baseline, during a single study visit
Agreement of LF/HF Ratio Across Different Analysis Durations
Baseline, during a single study visit
- +7 more secondary outcomes
Study Arms (1)
Healthy Adult Assessment Group
EXPERIMENTALHealthy adult participants will attend a single study visit and undergo resting hemodynamic and heart rate variability (HRV) assessment under standardized conditions. After an adaptation period, systolic blood pressure, diastolic blood pressure, and pulse will be measured using an automated oscillometric blood pressure monitor. A continuous RR interval recording will then be obtained using the Polar H10 chest strap. HRV parameters will be derived from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same recording for methodological comparison.
Interventions
Participants will complete a single-visit resting physiological assessment under standardized conditions. After an adaptation period, systolic blood pressure, diastolic blood pressure, and pulse will be measured using an automated oscillometric upper-arm blood pressure monitor. Continuous RR interval data will then be recorded using the Polar H10 chest strap and analyzed with Kubios HRV software. Heart rate variability parameters will be calculated from predefined 1-minute, 5-minute, 10-minute, and 20-minute analysis windows extracted from the same continuous recording for methodological comparison.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 18 to 40 years
- Willing and able to provide informed consent
- Able to comply with pre-assessment instructions, including restrictions related to caffeine intake and strenuous physical activity
- No condition preventing heart rate variability and blood pressure measurements
You may not qualify if:
- History of diagnosed cardiovascular, neurological, or autonomic nervous system disease
- Known arrhythmia or pacemaker use
- Regular use of medications that may affect heart rate variability, such as beta blockers or antiarrhythmic drugs
- Acute infection, fever, or any condition affecting general health status on the day of assessment
- Severe motion artifact during measurement or technically unusable recordings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sinop Universitylead
Study Sites (1)
Artvin Coruh University, Artvin Vocational School, Disabled Care and Rehabilitation Laboratory, Artvin,
Artvin, Turkey (Türkiye)
Related Publications (4)
Munoz ML, van Roon A, Riese H, Thio C, Oostenbroek E, Westrik I, de Geus EJ, Gansevoort R, Lefrandt J, Nolte IM, Snieder H. Validity of (Ultra-)Short Recordings for Heart Rate Variability Measurements. PLoS One. 2015 Sep 28;10(9):e0138921. doi: 10.1371/journal.pone.0138921. eCollection 2015.
PMID: 26414314BACKGROUNDThayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010 May 28;141(2):122-31. doi: 10.1016/j.ijcard.2009.09.543. Epub 2009 Nov 11.
PMID: 19910061BACKGROUNDHeart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
PMID: 8598068BACKGROUNDShaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. doi: 10.3389/fpubh.2017.00258. eCollection 2017.
PMID: 29034226BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 15, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
September 15, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share